A trial at Optegra Eye Hospital Hampshire saw patients receive drop-free, bilateral surgery with pre-op consultation and ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

Optegra Eye Hospital Hampshire announced being the first provider in the UK to offer NHS patients a pioneering treble of cataract care at one time.

Patients in both arms will be eligible for supplemental injections of aflibercept and will receive prophylactic steroid eye drops. ARTEMIS is the first of two planned Phase 3 registrational trials ...